DIALYSIS · CCN 372567

DaVita Southcrest Dialysis

TULSA, OK 74133

DialysisProfitDaVita
$4.7M
TOTAL REVENUE
26.0%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.7M
Total costs
$3.5M
Operating income (rev − costs)
$1.2M
Operating margin
26.0%
Total charges
$4.6M
Total treatments
9,930
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.0871—
Fistula Rate
DFC_FISTULA_RATE
57.793—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.4743—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
127.777—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.28——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2193—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
26.5340—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
8.874—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
28.763—
Standardized ED Visits Ratio
DFC_SEDR
1.240—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
11.132—